Background {#Sec1}
==========

Major depressive disorder (MDD) is one of the most common mental disorders and is characterized by persistent negative mood and altered cognitive functions \[[@CR1]\]. MDD is estimated to threaten the health of 16% of the entire global population and contributes substantially to the global burden of disease and disability \[[@CR2]\]. However, to date, the mechanisms underlying the development of depression remain unclear. In this context, plenty of studies have been directed to elucidate the pathophysiology of MDD, and MDD patients have been demonstrated to experience abnormalities of resting-state brain activity and deficits in cognitive function \[[@CR3], [@CR4]\].

In the last two decades, there have been a great amount of functional magnetic resonance imaging (fMRI) studies for MDD pointing to a role of functional brain impairments in the aetiology of the disease, and increasing evidence has accumulated for regional abnormalities within the limbic-cortical-striatal-pallidal-thalamic circuitry associated with MDD \[[@CR5]\]. Resting-state fMRI is an effective way to characterize the resting-state brain activity without any tasks that may represent more than 95% of the total activity of the brain \[[@CR6]\]. Recently, a high-quality meta-analysis summarized the previous findings of resting state fMRI studies in MDD, revealing a distributed pattern of brain regions with increased or decreased spontaneous activity in MDD. Decreased connectivity/activity in depression spatially converged mainly in the left superior/middle temporal gyrus and bilaterally in the insula, precuneus, superior frontal gyrus, lentiform nucleus and thalamus, while increased connectivity/activity was mainly found in the pre-/subgenual anterior cingulate cortex and neighbouring medial frontal cortex, the precuneus and neighbouring posterior cingulate cortex, bilaterally in the lateral prefrontal cortex with a left predominance, left lateral parietal cortex along with the right hippocampus and right cerebellum \[[@CR7]\].

With regard to cognitive function, although not always consistent, findings for neuropsychological impairments such as in attention \[[@CR8]\], memory \[[@CR9]\], executive functioning \[[@CR10]\], visuo-spatial processing and psychomotor function \[[@CR11]\] in MDD patients have been observed in an emerging body of investigations \[[@CR12]\]. Moreover, further studies have confirmed that cognitive dysfunction is observed not only in MDD patients with current mood episodes \[[@CR13]\] but also in patients during remission of MDD \[[@CR14]\]. Interestingly, a recent study by Vinberg et al. found that among healthy individuals with a heritable risk for affective disorder, onset of affective diseases in late life might be predicted by cognitive deficits, especially for executive function and attention \[[@CR15]\]. Altogether, these findings indicate that cognitive dysfunction may exist in the early stages and subsequently persist into the whole course of MDD and, importantly, that cognitive dysfunction may play a role as a trait marker of MDD.

In addition to these findings, task-related fMRI studies have identified a number of functionally aberrant cortical and subcortical areas in patients with depression during paradigms examining cognitive functions such as attention, working memory and executive processing \[[@CR16]\]. Performance in working memory tasks has been demonstrated to be associated with a dysfunctional activation of the medial orbitofrontal and rostral anterior cingulate cortex in MDD in a previous study \[[@CR17]\]. Meanwhile, executive deficits in MDD have been repeatedly associated with a dysfunction of prefrontal cortical regions \[[@CR18]\]. Taken together, all of these observations suggest that cognitive deficits might be associated with brain functional changes in MDD.

In a prior study, regional grey matter reduction has been proven to be related to cognitive deficits in MDD patients \[[@CR19]\]. Conversely, although abnormities of both resting-state brain activity and cognitive dysfunction are frequently observed in patients with MDD, the potential relationship between these two aspects is unknown and less investigated. In this context, the aim of the present study was to investigate the association between cognitive dysfunction and altered resting-state brain function in drug-naïve MDD patients. To assess the regional spontaneous activity, Zang and colleagues proposed an amplitude of low-frequency fluctuation (ALFF) method \[[@CR20]\]. Although the nature of the spontaneous low-frequency fluctuations (LFFs) is unclear, LFFs, which arise from neurovascular mechanisms \[[@CR21]\], are believed to be associated with regional spontaneous neuronal activity \[[@CR22]\]. However, ALFF is sensitive to the physiological noise; thus, Zou et al. proposed an improved ALFF method, namely, fractional ALFF (fALFF) approach to overcome this limitation \[[@CR23]\]. The fALFF approach is an advanced technique to measure local fluctuations in neuronal activity, rather than generalized neuronal activity, which can provide a more specific index of low frequency oscillatory phenomena \[[@CR24]\]. Compared to the traditional measurement of the ALFF, fALFF measurements have shown increased sensitivity and reduced bias from nonspecific physiological signal components \[[@CR23]\]. The fALFF method has been widely used to probe the neural basis of individual differences in several mental disorders \[[@CR25]\]. Motivated by previous work, we used fALFF in the current study.

Method {#Sec2}
======

Participants {#Sec3}
------------

The study group comprised 51 subjects (male/female, 17/34), aged 18--44 years, including 25 drug-naïve patients with first-episode MDD (depression group) and 26 healthy controls (control group). MDD patients were recruited from the department of Psychiatry in The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China. The inclusion criteria were as follows: 1) met the Diagnostic and Statistical Manual of Mental Disorders, IV Edition (DSM-IV) criteria for current first episode unipolar MDD, which was assessed using the Structured Clinical Interview for DSM-IV (SCID) by two professional psychiatrists; 2) completed at least a junior middle school level of education; 3) had a score ≥ 17 on the 17-item Hamilton Depression Scale (HAMD) \[[@CR26]\]; and 4) is of Han ethnicity and 5) right handed. Age- and sex-matched healthy volunteers were recruited from the local community and university via advertisements. The general exclusion criteria for all participants included were as follows: 1) treatment for depression; 2) significant medical illness; 3) a history of organic brain disease, cerebral trauma, seizure disorder, or MRI evidence of structural brain abnormalities; 4) the appearance of any other psychiatric axis-I or axis-II disorders (except MDD in patients) after SCID screening; 5) a family history of bipolar disorder; 6) a history of alcohol and drug abuse; 7) women pregnant, lactating or in a menstrual period, and 8) contraindications to MRI scan, including metallic implants, retractors or braces, and claustrophobia. Written informed consent was obtained, and this study was approved by the ethics committee of The First Affiliated Hospital, Zhejiang University School of Medicine.

Procedures {#Sec4}
----------

### Demographic and clinical assessments {#Sec5}

The diagnoses were ascertained through the consensus of two board-certified psychiatrists on the basis of clinical interviews and administrations of the Structured Clinical Interview for DSM-IV (SCID). The demographic and clinical data were collected using a self-designed questionnaire for all participants. The severity of mood symptoms was assessed by using the 17-item HAMD \[[@CR26]\], Hamilton Anxiety Rating Scale (HAMA) \[[@CR27]\] and Montgomery Asberg Depression Rating Scale (MADRS) \[[@CR28]\].

Neuropsychological tests {#Sec6}
------------------------

A well-known neuropsychological test battery on attention, memory, processing speed, behavioural inhibition and executive function was administered to each subject, which included the Wisconsin Card Sorting Test (WCST) \[[@CR29]\], Stroop Colour Word Test (SCWT) \[[@CR30]\], Continuous Performance Test (CPT) \[[@CR31]\], and Trail-making Test (TMT) \[[@CR32]\]. All of these tests have been demonstrated to reveal cognitive deficits in MDD patients in numerous previous studies \[[@CR19], [@CR33]\].Executive function was evaluated by using a computerized version of the WCST. This WCST comprised 48 cards and a maximum of 6 category switches. After 6 consecutive correct responses, subjects were asked to change the sorting principle to another category. The test ended when subjects completed all 6 categories correctly or used all 48 cards. We evaluated the primary efficacy outcome by using indices of the WCST for the performance of executive function that included total trials (TT), total correct (CT), total errors (TE), preservative errors (PE), random errors (RE), and categories completed.The SCWT was conducted to measure selective attention/processing speed (SCWT A and SCWT B), behavioural inhibition (SCWT C), and executive function (SCWT interference). First, the subjects were asked to read out three written colours printed in black ink as fast as possible (SCWT A). Then, the subjects were instructed to name the colour as fast as possible (SCWT B). Finally, the subjects were required to name the ink colour of a colour word as fast as possible (SCWT C). The colour word was not the same as the ink colour. The performance for each condition was calculated by the processing time per item in seconds. The reaction time difference in part C relative to part B is called the 'interference' effect. Two subtasks were included: written colour name differing from printed colour ink matching and speaking.The CPT was conducted to measure sustained and selective attention and impulsivity. It can be divided into 3 parts. In part 1, subjects were shown a series of numbers, and they were instructed to click the mouse whenever the number "4" was displayed. In part 2, eight numbers were shown, and they had to respond whenever a "4" was displayed. In part 3, eight numbers were shown, and they had to response whenever a "7" was displayed. The number of correct detections in all three parts and preservative errors in part 3 were measured.The TMT, given in two parts, was administered to evaluate attentive and executive functioning. In TMT-A, the subject was required to quickly draw lines to connect consecutively numbered circles. In TMT-B, the subject was asked to alternately combine numbers with letters in ascending order. The task completion was measured in seconds. Part A measures visuo-spatial attention and performance speed, whereas Part B requires mental flexibility, ability to shift attention, and strategy.

MRI acquisition {#Sec7}
---------------

Magnetic resonance imaging was performed by experienced professional staff in The First Affiliated Hospital, Zhejiang University School of Medicine using the Philips Magnetic Resonance Imaging Systems Achieva 3.0 T TX (Philips Healthcare, Netherlands). An 8-channel SENSE head coil was used to emit and receive MRI signals. Head movement was reduced using foam pads, and earplugs were used to reduce noise stimulation. The subjects were instructed to relax, keep their eyes closed, stay awake, remain still, and not think of anything in particular. The subjects' compliance was confirmed after the scanning was completed. First, a high-resolution T1-weighted sequence using a three-dimensional magnetization prepared rapid acquisition gradient echo sequence was used. Images of the whole brain were acquired in an axial orientation with the following parameters: repetition time (TR)/echo time (TE) = 7.5/3.7 ms, resolution = 240 × 227 matrix, slice thickness = 1 mm, 150 slices, field of view (FOV) = 240 mm × 240 mm, voxel size = 1 × 1 × 1 mm^3^, flip angle = 8°, and scan time = 4′15″. The functional images were recorded axially over 6′48″ using a field echo-planar imaging (EPI) sequence with the following parameters: TR/TE = 2000/35 ms, flip angle = 80°, 24 slices, slice thickness/gap = 5.0/1.0 mm, voxel size = 2.4 × 2.4 × 5.0 mm^3^, resolution = 100 × 100 matrix, FOV = 240 mm × 240 mm.

### Analysis of MRI data {#Sec8}

The first 10 functional volumes were discarded for signal equilibrium and patient adaptation to the scanning noise. Image preprocessing was performed using the Data Processing Assistant for RS-fMRI (DPARSF) version 2.0 software package (<http://restfmri.net/forum/DPARSF>) \[[@CR34]\], which was a convenient plug-in software in the Statistical Parametric Mapping 8 (SPM8, <http://www.fil.ion.ucl.ac.uk/spm>) and RS-fMRI Data Analysis Toolkit (REST, [http://www.restfmri.net](http://www.restfmri.net/)) \[[@CR35]\]. Functional data preprocessing included slice timing correction, motion correction, and spatial normalization. Head motion of more than either 2.0 mm maximum displacement in any of the x, y, or z directions or 2.5° in any angular motion throughout the course of the scan was found in any participant. The normalized functional data underwent spatial smoothing \[4-mm full width at half-maximum (FWHM) Gaussian kernel\] and removed the linear trend of time courses, as previously described \[[@CR21], [@CR36]\]. ALFF values were calculated using DPARSF software. The time series for each voxel was first transformed to the frequency domain using a fast Fourier transform (FFT), and then the sum of the frequencies in the low frequency band (0.01--0.08Hz) was computed. Quadratic detrending was not performed as the removal of filters below 0.01Hz was a non-linear detrending. The ALFF measure at each voxel was the averaged square root of the power in the 0.01--0.08Hz window, normalized by the mean within-brain ALFF value for that subject. This averaged square root was taken as the amplitude of LFF (ALFF, Eq. [1](#Equ1){ref-type=""}) \[[@CR20]\]. The fALFF value was the ratio of the power spectrum of low-frequency (0.01--0.08Hz) to that of the entire frequency range. In fact, as shown in Eq. [2](#Equ2){ref-type=""}, fALFF can be regarded as a normalized ALFF, using the total energy over the detectable frequency range \[[@CR37]\].$$\documentclass[12pt]{minimal}
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Statistical analysis {#Sec9}
--------------------

Between-group differences in demographic variables were examined using independent two-sample *t* tests for continuous variables and chi-square tests for categorical variables using the Statistical Package for the Social Sciences (SPSS) version 18.0 (IBM, Chicago, IL, USA). The level of two-tailed statistical significance was set at *p* \< 0.05 for all tests.

To explore the fALFF differences between two groups, a second-level random-effect two-sample *t* test was performed in a voxel-by-voxel manner. Significant differences were set at a corrected significance level of *p* \< 0.05 \[combined height threshold *p* \< 0.01 (*T* \> 2.40) and a minimum cluster size of 18 voxels\]. This correction was made using the AlphaSim program in the REST software (<http://restfmri.net/forum/rest>) with the parameter FWHM = 4 mm. This program applied the Monte Carlo simulation using both the individual voxel probability threshold and the cluster size to calculate the probability of detecting a false positive \[[@CR35]\].

Furthermore, to evaluate any correlations between fALFF values and cognitive tests, whole brain multiple regression analyses integrated in SPM basic models were performed, and the threshold was set at *p* \< 0.05, AlphaSim corrected. Then, the mean fALFF values of the surviving clusters were extracted by using region of interest (ROI) analyses. Correlations were conducted using Pearson's product moment.

Result {#Sec10}
======

Demographic, clinical, and neuropsychological testing results {#Sec11}
-------------------------------------------------------------

As indicated in Table [1](#Tab1){ref-type="table"}, the two groups did not significantly differ in age, gender, and education level. For the WSCT, patients with MDD completed significantly fewer categories than the healthy controls. In the CPT tests, MDD patients showed lower scores in the first and second subtests. However, there was no significant difference between the two groups in the SCWT and TMT. For more details, please refer to Table [2](#Tab2){ref-type="table"}.Table 1Demographic and clinical characteristics for all subjects (mean ± SD)Depression group (*n* = 25)Control group (*n* = 26)*p* valueAge (years)31.4 ± 7.2628.7 ± 7.610.200Gender (M/F)7/1810/160.428Education (years)12.0 ± 3.0912.5 ± 3.090.613Disease duration (months)12.1 ± 10.4HAMD25.6 ± 5.72MADRS31.8 ± 7.76HAMA25.9 ± 8.27*HAMD* Hamilton Depression Rating Scale, *MADRS* Montgomery-Asberg Depression Rating Scale, *HAMA* Hamilton Anxiety Rating Scale Table 2Comparisons of neuropsychological scores (Mean ± SD)Depression group (*n* =25)Control group (*n* = 26)*p* valueWSCTTT46.0 ± 6.5046.8 ± 2.190.552CT28.7 ± 9.6733.0 ± 7.550.172TE17.3 ± 8.5714.7 ± 8.710.276PE11.6 ± 8.139.15 ± 6.090.229RE5.48 ± 2.825.50 ± 3.300.982Categories3.52 ± 1.944.58 ± 1.680.042SCWTSCWT A47.4 ± 17.848.0 ± 24.40.916SCWT B77.4 ± 31.363.6 ± 21.30.070SCWT C117.8 ± 37.9103.4 ± 23.70.108SCWT interference40.3 ± 17.339.8 ± 16.40.920CPTCPT 19.36 ± 2.6610.7 ± 0.750.021CPT 29.12 ± 3.4211.1 ± 1.860.012CPT 310.8 ± 2.4411.5 ± 1.730.193CPT PE0.60 ± 1.261.04 ± 1.800.320TMT (s)TMT A63.4 ± 37.457.3 ± 40.80.583TMT B117.3 ± 61.697.7 ± 77.40.324*WSCT* Wisconsin Card Sorting Test, *TT* number of total trials, *CT* number of correct trials, *TE* total number of errors, *PE* preservative errors, *RE* random errors, *SWCT* Stroop Color Word Test, *CPT* Continuous Performance Test, *TMT* Trail-making test

Neuroimaging with fALFF {#Sec12}
-----------------------

MDD patients showed significantly lower fALFF values in the left superior frontal gyrus, left middle frontal gyrus, and left inferior frontal gyrus than that observed in the control group. Meanwhile, patients with MDD also showed increased fALFF values in the left inferior temporal gyrus, bilateral parahippocampal gyrus, and the right caudate. (see Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}).Fig. 1Brain regions showed decreased/increased fALFF values in depression patients as compared with normal controls (*p* \< 0.05, AlphaSim corrected). **a** Superior frontal gyrus; **b** Middle frontal gyrus; **c** Inferior frontal gyrus; **d** Inferior temporal gyrus; **e** left Parahippocampal gyrus; **f** right Parahippocampal gyrus; **g** Caudate Table 3Brain regions showing altered fALFF values in depression patients as compared with normal controls (*p* \< 0.05, AlphaSim corrected)Brain regionHemisphereCluster size*T* valueMNI coordinate*xyz*Decreased fALFF Superior frontal gyrusL19−5.06−36600 Middle frontal gyrusL29−3.94−33357 Inferior frontal gyrusL28−3.82−453018Increased fALFF Inferior temporal gyrusL333.59−420−33 Parahippocampal gyrusL423.33−24−15−18R193.77279−30 CaudateR294.92333*MNI* Montreal Neurological Institute

Correlations {#Sec13}
------------

In MDD patients, the whole-brain linear regression analyses conducted with SPM8 revealed that fALFF values in the left superior frontal gyrus (*x* = -3, *y* = 57, *z* = 36, cluster = 23, *T* = 3.63) and left inferior temporal gyrus (*x* = -57, *y* = -54, *z* = -9, cluster = 22, *T* = -3.87) were associated with the number of WSCT completed categories and CPT-2 scores, respectively. (see Fig. [2](#Fig2){ref-type="fig"}). These associations were not found in healthy controls.Fig. 2Correlation analysis between cognitive deficits and fALFF values in depression patients (*p* \< 0.05, corrected). SFG, Superior frontal gyrus; ITG, Inferior temporal gyrus

Discussion {#Sec14}
==========

In this study, cognitive function and resting-state brain function as revealed by fALFF were tested in first-episode drug-naïve MDD patients. The current findings suggested that MDD patients exhibited cognitive dysfunction in many aspects, including executive function, sustained and selective attention, and impulsivity. Meanwhile, this study also demonstrated that extensive regions involved in mood regulation and cognitive function showed altered resting-state brain function in MDD patients. Moreover, the correlation analyses revealed that cognitive deficits might be associated with regional abnormalities in resting-state brain function. To our knowledge, the present results are consistent with currently available functional neuroimaging and neuropsychological findings in MDD \[[@CR13], [@CR38]\].

Cognitive dysfunction in MDD patients has been commonly reported in prior studies. A meta-analysis of all studies published between 1975 and 1997 indicated that individuals with major depression were shown to have a consistent global-diffuse impairment in brain functions, with particular involvement of the frontal lobes, as characterized by executive dysfunction \[[@CR39]\]. In another meta-analysis, McDermott et al. further reported significant correlations between depression severity and executive dysfunction; moreover, they demonstrated that there were positive associations between depression severity and cognitive deficits in the domains of episodic memory and processing speed as well \[[@CR40]\]. Together with our results, these findings indicate that several aspects of cognitive impairment exist in MDD patients. However, the present study did not find any group differences in the SCWT and TMT. This might result from a heterogeneity of research samples since the mean disease course of MDD patients was relatively short and all of the patients in our study sample were experiencing their first episode of depression. Furthermore, the relatively high educational level in our sample could be another influential factor. People with higher educational levels have been reported to have greater cognitive reserve than those with lower educational levels, and this cognitive reserve might enable individuals to sustain brain damage and maintain function \[[@CR41]\].

In the present study, significant functional abnormalities in brain regions involved in mood regulation and cognitive function \[[@CR42]\] were identified in MDD patients, which was generally consistent with most previous findings. Our data were, at least in part, comparable with findings of a prior resting-state fMRI study which demonstrated that depression patients showed higher fALFF values in the left temporal subgyral region and lower fALFF values in the right frontal subcallosal gyrus. Interestingly, this study found an association between severity of depressive symptoms and altered resting-state brain function in depression patients as well \[[@CR43]\]. In addition, previous resting-state fMRI studies using the fALFF method also reported that MDD patients showed altered brain function in widespread regions, including the parahippocampal gyrus, middle frontal gyrus, median frontal gyrus, and inferior temporal gyrus \[[@CR44]--[@CR47]\], which was comparable with our findings.

Moreover, the current study also explored the relationship between these MDD-associated brain functional abnormalities and cognitive deficits, potentially linking resting-state brain dysfunction with behavioural manifestations of MDD. In a recent study, regional grey matter reduction has been proven to be related with cognitive deficits in MDD patients. Impaired WCST performance was associated with decreased grey matter concentration in the left inferior temporal cortex, right orbitofrontal cortex, and right dorsolateral prefrontal cortex \[[@CR19]\]. In fMRI studies, working memory and executive deficits in MDD have also been demonstrated to be associated with dysfunction of prefrontal cortical regions \[[@CR48]\]. In the present study, we found that executive dysfunction was associated with altered activity of the left superior frontal gyrus in MDD patients but not healthy controls. The superior frontal gyrus is involved in cognitive processes, such as executive function and memory retrieval \[[@CR49]\], which may help to explain the current association found in MDD patients. Furthermore, a negative association between the CPT-2 scores and fALFF values in the left inferior temporal gyrus was observed in MDD patients as well. In a previous study, it was reported that decreased metabolism of the inferior temporal gyrus was correlated with poor performance in the CPT in schizophrenia patients \[[@CR50]\], which suggested that the attention deficit might be due to dysfunction of the inferior temporal gyrus, but it is still unclear how this region is related to attentional function. Taken together, these findings may help to provide evidence for elucidating the potential brain mechanisms underlying cognitive impairments in MDD.

Limitations {#Sec15}
===========

Some limitations must be considered when interpreting our findings. First, the size of the study sample could be an issue. Although it was suitable for fALFF analysis, the sample size in each group was relatively small, which might result in some subtle functional changes in the brain not being observed \[[@CR51]\]. In addition, the inclusion criteria for education level in this study might be a possible bias and confounding issue. Furthermore, the slice thickness and the parameter of the EPI sequence may have limited the resolution and accuracy of the fALFF results. Additionally, the present study was cross-section designed, restricting causal analysis. Finally, in the current analyses, only changes in regional connectivity could be detected, and it was not possible to determine how MDD affected the interactions among brain network systems.

Conclusions {#Sec16}
===========

In conclusion, the present findings suggest that there is little evidence of an association between regional abnormalities in resting-state brain function and cognitive deficits in MDD.
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